Clinical Trial Update: Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicates completion of a study evaluating the safety and efficacy of piperacillin/tazobactam and ampicillin/sulbactam in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Infection

Drugs mentioned

• UNASYN (Ampicillin sodium and sulbactam sodium)
• Zosyn (Piperacillin/tazobactam)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Diabetes Mellitus, Diabetic Foot | Phase 4 | Status: COMPLETED